Jiangxi Rimag Group Co., Ltd. (2522.HK)
- Previous Close
19.400 - Open
19.160 - Bid 18.720 x --
- Ask 18.740 x --
- Day's Range
18.540 - 19.320 - 52 Week Range
13.500 - 71.950 - Volume
3,683,000 - Avg. Volume
3,890,469 - Market Cap (intraday)
6.809B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.140 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
52.70
Jiangxi Rimag Group Co., Ltd. invests and operates medical imaging centers in China. It operates through Imaging center Services; Imaging Solution Services; and Rimag Cloud Services segments. The company offers imaging examination and diagnostic service, such as MRI, CT, PET, X-ray, ultrasound, fluoroscopy, and other related procedures; and Rimag Cloud services, including cloud storage and cloud film, cloud radiology information system, remote/difficult disease consultation, quality control, remote hosting services, refined operation management, and imaging AI integration platform modules and operational management modules. It also operates and manages medical imaging platform that provides diversified imaging services; research and development center; sells medical equipment and consumables; and provides operational management services. Jiangxi Rimag Group Co., Ltd. was incorporated in 2014 and is headquartered in Beijing, China.
www.rimag.com.cn1,342
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2522.HK
View MorePerformance Overview: 2522.HK
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2522.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2522.HK
View MoreValuation Measures
Market Cap
6.81B
Enterprise Value
7.15B
Trailing P/E
--
Forward P/E
161.29
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.94
Price/Book (mrq)
4.36
Enterprise Value/Revenue
8.75
Enterprise Value/EBITDA
39.32
Financial Highlights
Profitability and Income Statement
Profit Margin
-6.04%
Return on Assets (ttm)
-1.10%
Return on Equity (ttm)
-4.18%
Revenue (ttm)
760.59M
Net Income Avi to Common (ttm)
-45.92M
Diluted EPS (ttm)
-0.140
Balance Sheet and Cash Flow
Total Cash (mrq)
288.69M
Total Debt/Equity (mrq)
39.09%
Levered Free Cash Flow (ttm)
-316.51M